The clinical significance of malfunction of the CD44 locus in malignancy

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Neuro-Oncology

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01052624PMID 8750187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanism of stomach carcinogenesis

  2005cited by this paper
• Venular endothelium binding molecules CD44 and LECAM-1 in normal and malignant B-cell populations. A comparative study

  2005cited by this paper
• Demonstration of CD44 gene expression in cells from fine needle aspirates of breast lesions by the polymerase chain reaction

  1995cited by this paper
• CD44 variant exon epitopes in primary breast cancer and length of survival.

  1995influential reference
• Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities

  1995cited by this paper
• Prognostic significance of CD44 expression in adenocarcinoma of the lung

  1995cited by this paper
• Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine

  1995cited by this paper
• Serum CD44 in malignant lymphoma: an association with treatment response.

  1994influential reference
• Expression of CD44 in prostate cancer cells.

  1994cited by this paper
• Serum Cd44 in Malignant Lymphoma: an Association with Treatment Response

  1994cited by this paper
• Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.

  1994cited by this paper
• Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.

  1994cited by this paper
• Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.

  1994cited by this paper
• Expression of CD44 in human lung tumors.

  1994cited by this paper
• Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential

  1994cited by this paper
• Expression of alternatively spliced forms of the CD44 extracellular‐matrix receptor on human lung carcinomas

  1994influential reference
• Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.

  1994influential reference
• Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells

  1994cited by this paper
• CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.

  1994cited by this paper
• Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.

  1994cited by this paper
• Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas.

  1994cited by this paper
• Expression of CD44 abnormal transcripts in human gastric carcinomas.

  1994cited by this paper
• Expression of the CD44 adhesion molecule in primary and metastatic gynecologic malignancies and their cell lines

  1994cited by this paper
• Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.

  1994cited by this paper
• Expression of integrins and CD44 isoforms in non‐Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high‐grade malignant lymphomas

  1994influential reference
• CD44 and its interaction with extracellular matrix.

  1993cited by this paper
• The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate.

  1993cited by this paper
• De-novo expression of CD44 and survival in gastric cancer.

  1993cited by this paper
• Glycoprotein CD44 expression and its association with survival in breast cancer.

  1993cited by this paper
• Novel variants of CD44 arising from alternative splicing: Changes in the CD44 alternative splicing pattern of MCF‐7 breast carcinoma cells treated with hyaluronidase

  1993cited by this paper
• Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44

  1993cited by this paper
• Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

  1993cited by this paper
• Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.

  1993cited by this paper
• Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin

  1993cited by this paper
• CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells.

  1993cited by this paper
• Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.

  1993cited by this paper
• A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps

  1993cited by this paper
• Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain.

  1992cited by this paper
• Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

  1992cited by this paper
• Significance of CD44 gene products for cancer diagnosis and disease evaluation.

  1992cited by this paper
• Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

  1992cited by this paper
• Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells

  1991cited by this paper
• CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.

  1991cited by this paper
• Distinct effects of two CD44 isoforms on tumor growth in vivo

  1991cited by this paper
• Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons

  1991cited by this paper
• Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.

  1991cited by this paper
• The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells.

  1991cited by this paper
• Expression of CD44 is repressed in neuroblastoma cells

  1991cited by this paper
• A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

  1991cited by this paper
• Expression of adhesion structures during B cell development in man.

  1989cited by this paper
• CD44--a molecule involved in leukocyte adherence and T-cell activation.

  1989cited by this paper
• A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.

  1989influential reference
• Antibody which defines a subset of bone marrow cells that can migrate to thymus.

  1989cited by this paper
• Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man.

  1988cited by this paper
• Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma.

  1988cited by this paper

• Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.

  2010cites this paper
• CD44 Gene Expression in Invasive Bladder Cancer

  2007cites this paper
• Observed mRNA and Protein Isoforms

  2007cites this paper
• Potential gene therapy strategies for cancer stem cells.

  2006cites this paper
• Cancer Stem Cells and Differentiation Therapy

  2006cites this paper
• Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants.

  2005cites this paper
• Motility of colon cancer cells: modulation by CD44 isoform expression.

  2003cites this paper
• Variant expression of CD44 in preneoplastic lesions of the lung

  2001cites this paper
• CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.

  1999cites this paper
• Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.

  1999cites this paper
• Current status of CD44 variant isoforms as cancer diagnostic markers

  1998cites this paper
• Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions

  1998cites this paper
• PCR Analysis of CD44 Variants in Tumors.

  1998cites this paper
• Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse

  1998cites this paper
• Utilization of polymerase chain reaction technology in the detection of solid tumors

  1998cites this paper
• Exfoliated oral cell messenger RNA: suitability for biomarker studies.

  1998cites this paper
• CD44 expression in human breast cancer cell lines is related to oestrogen receptor (ER) status and confluency in vitro.

  1997cites this paper
• CD44: structure, function, and association with the malignant process.

  1997cites this paper
• Differential expression of CD44 variants among meningioma subtypes

  1996cites this paper
• Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.

  1996cites this paper
• Progressive loss of CD44 gene expression in invasive bladder cancer.

  1996cites this paper
• Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation

  1996cites this paper
• To metastasize or not? Selection of CD44 splice sites

  1995cites this paper